Literature DB >> 17057196

Immunology of Crohn's disease.

Henri Braat1, Maikel P Peppelenbosch, Daan W Hommes.   

Abstract

The immense microbiological load of the gastrointestinal tract poses a daunting challenge for the mucosal immune system: whereas it should tolerate the vast number of commensal bacteria, it should adequately attack pathogenic organisms. Millions of years of co-evolution have produced an intricate system in which interactions between the endogenous flora and mucosal immune system manage to perform this difficult balancing act. When components of this interaction are defective, for instance by mutation, inflammatory bowel disease may result. In the present review, we comprehensively discuss the mucosal immune system in the context of Crohn's disease (CD) and its genetic risk factors, describe the clinical management of the disease, and discuss how knowledge of the mucosal immune system may yield novel therapeutical avenues for dealing with this debilitating disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17057196     DOI: 10.1196/annals.1326.039

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  12 in total

1.  Linkage between genotype and immunological phenotype in Crohn's disease.

Authors:  Gwenny M Fuhler; Kaushal Parikh; C Janneke van der Woude; Maikel P Peppelenbosch
Journal:  Ann Transl Med       Date:  2015-09

Review 2.  Role of defective autophagia and the intestinal flora in Crohn disease.

Authors:  Anouk Regeling; Rajesh Somasundaram; Colin de Haar; C Janneke van der Woude; Henri Braat; Maikel P Peppelenbosch
Journal:  Self Nonself       Date:  2010 Oct-Dec

Review 3.  Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.

Authors:  Mohammad Salem; Jakob Benedict Seidelin; Gerhard Rogler; Ole Haagen Nielsen
Journal:  Cell Mol Life Sci       Date:  2012-12-29       Impact factor: 9.261

4.  Impact of human granulocyte and monocyte isolation procedures on functional studies.

Authors:  Lu Zhou; Rajesh Somasundaram; Rosa F Nederhof; Gerard Dijkstra; Klaas Nico Faber; Maikel P Peppelenbosch; Gwenny M Fuhler
Journal:  Clin Vaccine Immunol       Date:  2012-05-02

5.  Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.

Authors:  A Brosbøl-Ravnborg; C L Hvas; J Agnholt; J F Dahlerup; I Vind; A Till; P Rosenstiel; P Höllsberg
Journal:  Clin Exp Immunol       Date:  2008-12-15       Impact factor: 4.330

Review 6.  Steroid-refractory severe ulcerative colitis: what are the available treatment options?

Authors:  Alan C Moss; Mark A Peppercorn
Journal:  Drugs       Date:  2008       Impact factor: 9.546

7.  Hyperactivated B cells in human inflammatory bowel disease.

Authors:  Ansu Mammen Noronha; YanMei Liang; Jeremy T Hetzel; Hatice Hasturk; Alpdogan Kantarci; Arthur Stucchi; Yue Zhang; Barbara S Nikolajczyk; Francis A Farraye; Lisa M Ganley-Leal
Journal:  J Leukoc Biol       Date:  2009-07-09       Impact factor: 4.962

Review 8.  The epidemiology and pathogenesis of neoplasia in the small intestine.

Authors:  David Schottenfeld; Jennifer L Beebe-Dimmer; Fawn D Vigneau
Journal:  Ann Epidemiol       Date:  2009-01       Impact factor: 3.797

9.  DomainRBF: a Bayesian regression approach to the prioritization of candidate domains for complex diseases.

Authors:  Wangshu Zhang; Yong Chen; Fengzhu Sun; Rui Jiang
Journal:  BMC Syst Biol       Date:  2011-04-19

10.  Functional mapping and annotation of genetic associations with FUMA.

Authors:  Kyoko Watanabe; Erdogan Taskesen; Arjen van Bochoven; Danielle Posthuma
Journal:  Nat Commun       Date:  2017-11-28       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.